ClotTriever系统治疗下肢深静脉血栓的技术成功率与短期结局:初步经验
所有患者单次手术实现完全血栓清除,出院前症状全部缓解,无术后贫血或急性肾衰竭,平均住院2天。早期随访91.7%患者症状持续缓解,但10例复查超声中2例出现复发性闭塞性DVT。
要点
- ClotTriever系统单次手术即可实现下肢急性DVT完全血栓清除,无需溶栓治疗。
- 术后无贫血或急性肾衰竭,无需ICU入住,平均住院2天。
- 早期随访91.7%症状持续缓解,但20%(2/10)出现复发性闭塞性DVT。
核心结论
- 该新型经皮静脉血栓切除系统可单次清除大量下肢急性血栓,安全有效,无需溶栓治疗、ICU入住或重复干预。
研究设计与样本
- 队列50%为女性(6例),平均年龄55.6岁(范围32-86岁)。
- 技术成功定义为干预后完全血栓清除。
主要发现
- 所有患者单次手术实现完全血栓清除,无重复干预。
- 出院前症状缓解率达100%。
- 术后平均血红蛋白10.7 g/dL(术前)vs 10.4 g/dL(术后),无术后贫血。
- 平均肌酐0.86 mg/dL(术前)vs 0.81 mg/dL(术后),无急性肾衰竭。
- 早期随访11例(91.7%)症状持续显著缓解,10例复查超声中2例(20%)出现复发性闭塞性DVT。
临床怎么用
- 对于下肢急性DVT,可考虑使用ClotTriever系统行单次经皮机械血栓清除,无需同期溶栓。
- 术后无需常规ICU监护,平均住院2天,但需关注早期随访中的DVT复发。
局限性
- 随访为早期,中远期结局尚不明确。
- 原文结论指出需进一步研究确定中期和长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep vein thrombosis (DVT) may be associated with significant pain, swelling and the development of post-thrombotic syndrome. Early clot removal is facilitated by the use of percutaneous mechanical thrombectomy devices. Current techniques, however, vary in rates of technical success and in some cases are limited by the concomitant need for thrombolytics. An alternative percutaneous venous thrombectomy system (ClotTriever, Inari Medical, Irvine, Calif) may be helpful in the management of lower extremity DVT without the concomitant use of thrombolytics. METHODS: A retrospective review of patients treated for DVT using the device was conducted. Demographics, initial presentation, and perioperative course were recorded. Outcomes after treatment were extracted from clinical records. Technical success was defined as complete clot evacuation after intervention. RESULTS: Twelve patients were included in the study. The cohort was 50% female (6 patients) with a mean age of 55.6 years (range, 32-86 years). Two patients (16.7%) presented with chronic asymptomatic DVT who developed symptoms from an acute, recurrent iliofemoral DVT over the days before presentation. One patient (8.4%) presented with phlegmasia cerulea dolens, with the remaining patients presenting with disabling pain and swelling. Access was obtained via the popliteal vein (11 patients) and small saphenous vein (1 patient). Lytic therapy was not used in any case. Complete clot evacuation was obtained in all patients in a single session without repeat interventions. Symptom resolution before discharge was achieved in 100% of cases. There was no incidence of postoperative anemia (mean hemoglobin, 10.7 g/dL preoperatively vs 10.4 g/dL postoperatively) or acute kidney failure (mean creatinine, 0.86 mg/dL preoperatively vs 0.81 mg/dL postoperatively). The average length of stay was 2 days (range, 1-4 days) without the need for intensive care admission. At early follow-up, 11 patients (91.7%) continued to report significant symptom resolution. Two of 10 patients (20%) developed recurrent occlusive DVTs on follow-up duplex ultrasound examination. CONCLUSIONS: This novel percutaneous venous thrombectomy system is safe and effective for removing large volumes of lower extremity acute thrombus in a single session, without the need for lytic therapy, intensive care unit admission, or repeat intervention. Further studies are warranted to determine mid-term and long-term outcomes.
引用
- Benarroch-Gampel J, Pujari A, Aizpuru M, et al. Technical success and short-term outcomes after treatment of lower extremity deep vein thrombosis with the ClotTriever system: A preliminary experience. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31843476. doi:10.1016/j.jvsv.2019.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。